1:1 match to funding from MEDTEQ/CQDM, up to 40% of the total project cost
The maximum contribution from HBHL is $200,000
|Requests for co-funding from HBHL should be submitted at least 3 weeks before the CQDM or MEDTEQ deadlines|
Under this program, Healthy Brains, Healthy Lives (HBHL) provides 1:1 matching funds for projects with a high potential impact on biopharmaceutical research through existing programs offered by the Ministère de l'Économie et de l'Innovation (MEI). Co-funding is available for up to 40% of the total project cost but the maximum contribution from HBHL is $200,000.
MEI co-funding is available through:
- CQDM Quantum Leap and SynergiQc programs
- MEDTEQ Industrial Consortium for Research and Innovation in Medical Technologies
The project must be within the field of neuroscience, align with HBHL's Strategic Research Plan, and comply with the eligibility criteria of HBHL and the partner agency (CQDM or MEDTEQ). Specifically,
- CQDM and MEDTEQ require that at least one of the project partners be a company registered in the Province of Quebec
- HBHL requires that the Principal Investigator be McGill University faculty and be eligible to hold Tri-Agency research funding
Applications must be submitted during regular CQDM and MEDTEQ competitions. Project timelines will follow the schedules established by CQDM and MEDTEQ. Please submit your application for HBHL co-funding at least 3 weeks in advance of the CQDM or MEDTEQ deadlines.
Applicants may seek co-funding from HBHL for a proposal submitted to CQDM or MEDTEQ during their regular competitions. To be eligible for HBHL funding, applicants must:
- Ensure that requests for co-funding are supported by documentation that complies with the application criteria of both HBHL and the partner agency, CQDM or MEDTEQ
- Complete the HBHL online submission form, upload the completed CQDM or MEDTEQ application package and upload a certificate of completion (incl. name and date) from at least one of CIHR’s Online Training Modules on Integrating Sex and Gender in Health Research
- Please submit the package 3 weeks ahead of the CQDM or MEDTEQ deadline
The HBHL Innovation Committee (IC) will designate a review panel consisting of internal and external experts to evaluate each application in regard to:
- Alignment with HBHL Research Themes
- Relevance to HBHL objectives
- Whether the funding request is reasonable in relation to the scope of work, total project budget, and other partner contributions
The McGill Innovation and Partnerships (I+P) Office will complete an Intellectual Property (IP) and commercialization assessment for each application, which will be sent to the IC along with the assessment conducted by the reviewers. The IC will then make a recommendation to the Scientific Steering Committee (SSC), which will make the final decision on the HBHL contribution. All HBHL co-funding is conditional upon obtaining an award from CQDM or MEDTEQ.
- All applicants will be notified by email of the results of their application
- Successful applicants will be sent a Notice of Award (NoA)
For additional information: hbhl [at] mcgill.ca (subject: Neuro-Partnerships%20Program)